Cargando…

The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes

The prevalence of non-alcoholic fatty-liver disease (NAFLD) is increasing globally. NAFLD is a spectrum of related liver diseases that progressive from simple steatosis to serious complications like cirrhosis. The major pathophysiological driving of NAFLD includes elevated hepatic adiposity, increas...

Descripción completa

Detalles Bibliográficos
Autores principales: Salley, Tatiana Ntube, Mishra, Manish, Tiwari, Shuchita, Jadhav, Ashok, Ndisang, Joseph Fomusi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829851/
https://www.ncbi.nlm.nih.gov/pubmed/24260182
http://dx.doi.org/10.1371/journal.pone.0079270
_version_ 1782291402232692736
author Salley, Tatiana Ntube
Mishra, Manish
Tiwari, Shuchita
Jadhav, Ashok
Ndisang, Joseph Fomusi
author_facet Salley, Tatiana Ntube
Mishra, Manish
Tiwari, Shuchita
Jadhav, Ashok
Ndisang, Joseph Fomusi
author_sort Salley, Tatiana Ntube
collection PubMed
description The prevalence of non-alcoholic fatty-liver disease (NAFLD) is increasing globally. NAFLD is a spectrum of related liver diseases that progressive from simple steatosis to serious complications like cirrhosis. The major pathophysiological driving of NAFLD includes elevated hepatic adiposity, increased hepatic triglycerides/cholesterol, excessive hepatic inflammation, and hepatocyte ballooning injury is a common histo-pathological denominator. Although heme-oxygenase (HO) is cytoprotective, its effects on hepatocyte ballooning injury have not been reported. We investigated the effects of upregulating HO with hemin or inhibiting it with stannous-mesoporphyrin (SnMP) on hepatocyte ballooning injury, hepatic adiposity and inflammation in Zucker-diabetic-fatty rats (ZDFs), an obese type-2-diabetic model. Hemin administration to ZDFs abated hepatic/plasma triglycerides and cholesterol, and suppressed several pro-inflammatory cytokines and chemokines including, TNF-α, IL-6, IL-1β, macrophage-inflammatory-protein-1α (MIP-1α) and macrophage-chemoattractant-protein-1 (MCP-1), with corresponding reduction of the pro-inflammatory M1-phenotype marker, ED1 and hepatic macrophage infiltration. Correspondingly, hemin concomitantly potentiated the protein expression of several markers of the anti-inflammatory macrophage-M2-phenotype including ED2, IL-10 and CD-206, alongside components of the HO-system including HO-1, HO-activity and cGMP, whereas the HO-inhibitor, SnMP abolished the effects. Furthermore, hemin attenuated liver histo-pathological lesions like hepatocyte ballooning injury and fibrosis, and reduced extracellular-matrix/profibrotic proteins implicated in liver injury such as osteopontin, TGF-β1, fibronectin and collagen-IV. We conclude that hemin restore hepatic morphology by abating hepatic adiposity, suppressing macrophage infiltration, inflammation and fibrosis. The selective enhancement of anti-inflammatory macrophage-M2-phenotype with parallel reduction of pro-inflammatory macrophage-M1-phenotype and related chemokines/cytokines like TNF-α, IL-6, IL-1β, MIP-1α and MCP-1 are among the multifaceted mechanisms by which hemin restore hepatic morphology.
format Online
Article
Text
id pubmed-3829851
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38298512013-11-20 The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes Salley, Tatiana Ntube Mishra, Manish Tiwari, Shuchita Jadhav, Ashok Ndisang, Joseph Fomusi PLoS One Research Article The prevalence of non-alcoholic fatty-liver disease (NAFLD) is increasing globally. NAFLD is a spectrum of related liver diseases that progressive from simple steatosis to serious complications like cirrhosis. The major pathophysiological driving of NAFLD includes elevated hepatic adiposity, increased hepatic triglycerides/cholesterol, excessive hepatic inflammation, and hepatocyte ballooning injury is a common histo-pathological denominator. Although heme-oxygenase (HO) is cytoprotective, its effects on hepatocyte ballooning injury have not been reported. We investigated the effects of upregulating HO with hemin or inhibiting it with stannous-mesoporphyrin (SnMP) on hepatocyte ballooning injury, hepatic adiposity and inflammation in Zucker-diabetic-fatty rats (ZDFs), an obese type-2-diabetic model. Hemin administration to ZDFs abated hepatic/plasma triglycerides and cholesterol, and suppressed several pro-inflammatory cytokines and chemokines including, TNF-α, IL-6, IL-1β, macrophage-inflammatory-protein-1α (MIP-1α) and macrophage-chemoattractant-protein-1 (MCP-1), with corresponding reduction of the pro-inflammatory M1-phenotype marker, ED1 and hepatic macrophage infiltration. Correspondingly, hemin concomitantly potentiated the protein expression of several markers of the anti-inflammatory macrophage-M2-phenotype including ED2, IL-10 and CD-206, alongside components of the HO-system including HO-1, HO-activity and cGMP, whereas the HO-inhibitor, SnMP abolished the effects. Furthermore, hemin attenuated liver histo-pathological lesions like hepatocyte ballooning injury and fibrosis, and reduced extracellular-matrix/profibrotic proteins implicated in liver injury such as osteopontin, TGF-β1, fibronectin and collagen-IV. We conclude that hemin restore hepatic morphology by abating hepatic adiposity, suppressing macrophage infiltration, inflammation and fibrosis. The selective enhancement of anti-inflammatory macrophage-M2-phenotype with parallel reduction of pro-inflammatory macrophage-M1-phenotype and related chemokines/cytokines like TNF-α, IL-6, IL-1β, MIP-1α and MCP-1 are among the multifaceted mechanisms by which hemin restore hepatic morphology. Public Library of Science 2013-11-15 /pmc/articles/PMC3829851/ /pubmed/24260182 http://dx.doi.org/10.1371/journal.pone.0079270 Text en © 2013 Salley et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Salley, Tatiana Ntube
Mishra, Manish
Tiwari, Shuchita
Jadhav, Ashok
Ndisang, Joseph Fomusi
The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes
title The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes
title_full The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes
title_fullStr The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes
title_full_unstemmed The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes
title_short The Heme Oxygenase System Rescues Hepatic Deterioration in the Condition of Obesity Co-Morbid with Type-2 Diabetes
title_sort heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829851/
https://www.ncbi.nlm.nih.gov/pubmed/24260182
http://dx.doi.org/10.1371/journal.pone.0079270
work_keys_str_mv AT salleytatianantube thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT mishramanish thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT tiwarishuchita thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT jadhavashok thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT ndisangjosephfomusi thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT salleytatianantube hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT mishramanish hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT tiwarishuchita hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT jadhavashok hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes
AT ndisangjosephfomusi hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes